Consolidated Statements of Operations and Comprehensive Loss - USD ($)
|
12 Months Ended |
Dec. 31, 2017 |
Dec. 31, 2016 |
| Net revenue: |
|
|
| Product revenues |
$ 3,544,000
|
$ 2,093,000
|
| License, royalty and other revenues |
265,000
|
227,000
|
| Total net revenues |
3,809,000
|
2,320,000
|
| Cost of goods sold |
1,517,000
|
1,026,000
|
| Gross margin |
2,292,000
|
1,294,000
|
| Operating expenses: |
|
|
| Research and development |
1,002,000
|
1,079,000
|
| Depreciation and amortization |
218,000
|
230,000
|
| Selling, general and administrative |
3,298,000
|
2,854,000
|
| Total operating expenses |
4,518,000
|
4,163,000
|
| Loss from operations |
(2,226,000)
|
(2,869,000)
|
| Interest expense |
(302,000)
|
(172,000)
|
| Interest income |
4,000
|
5,000
|
| Other income (expense), net |
(74,000)
|
4,000
|
| Loss before income taxes |
(2,598,000)
|
(3,032,000)
|
| Income tax benefit |
1,789,000
|
|
| Net loss |
(809,000)
|
(3,032,000)
|
| Other comprehensive income (loss), foreign currency translation adjustments, net of tax |
10,000
|
(4,000)
|
| Total comprehensive loss |
$ (799,000)
|
$ (3,036,000)
|
| Net loss per common share, basic and diluted |
$ (0.02)
|
$ (0.06)
|
| Weighted average common shares outstanding, basic and diluted |
52,935,728
|
48,583,165
|